We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
16 Feb 2023 - 18 Feb 2023

Implantable Septal Shunt Improves Cardiac Function

By HospiMedica International staff writers
Posted on 11 Jan 2021
Print article
Image: The Occlutech implantable atrial flow regulator (AFR) (Photo courtesy of Occlutech)
Image: The Occlutech implantable atrial flow regulator (AFR) (Photo courtesy of Occlutech)
An implantable atrial flow regulator (AFR) substantially reduces intra-cardiac pressure resulting from pulmonary arterial hypertension (PAH).

The Occlutech (Schaffhausen, Switzerland) AFR is a nickel-titanium (nitinol) shunt placed into the septum between the left and right atriums via balloon atrial septostomy (BAS), in order to create a permanent interatrial fenestration. By selecting and maintaining correct sizing of the created shunt (between six and 10 mm), the AFR allows for a controlled, restricted flow of blood between the atria, thus reducing intra-cardiac pressure and improving the heart's function.

The AFD is intended for heart failure patients with a preserved ejection fraction (HFpEF) that includes diminished left ventricle relaxation and elevated filling pressures. By creating a communication between both atria using BAS, decompression of the left atrium is achieved. The design of the device was based on the concept of the Lutembacher syndrome, a medical condition defined as a combination of mitral stenosis and atrial septal defect (ASD).

PAH is a rare, progressive disorder characterized by high blood pressure in the pulmonary artery for no apparent reason. Symptoms of PAH include shortness of breath (dyspnea) especially during exercise, chest pain, and fainting episodes. Advanced stages of PAH may manifest in cyanosis due to low levels of circulating oxygen. In severe cases of PAH, the right ventricle is abnormally enlarged, potentially leading to right heart failure.

Related Links:
Occlutech

Gold Supplier
12-Channel ECG
CM1200B
New
Surgical Table
ARCUS 601
New
Endoscopy Display
EndoVue Plus 24”
New
Medical Furniture
Varimed

Print article

Channels

AI

view channel
Image: MyoVista Wavelet technology utilizes AI for early detection of heart disease (Photo courtesy of Heart Test Laboratories)

Novel ECG Technology Utilizes AI for Early Detection of Heart Disease

Cardiovascular disease is responsible for 17.9 million deaths every year, or about 32% of all deaths worldwide. Every week, millions of electrocardiographs (ECGs) are performed across the world, making... Read more

Surgical Techniques

view channel
Image: The Vena BDAC provides a superior solution to distal navigation (Photo courtesy of Vena Medical)

Category-Defining Balloon Distal Access Catheter Allows Surgeons to Get Much Closer to Blood Clots

Thrombectomy is a minimally invasive procedure for removing a blood clot and has now become standard of care treatment for patients with an acute ischemic stroke (AIS) secondary to a Large Vessel Occlusion (LVO).... Read more

Health IT

view channel
Image: Using digital data can improve health outcomes (Photo courtesy of Unsplash)

Electronic Health Records May Be Key to Improving Patient Care, Study Finds

When a patient gets transferred from a hospital to a nearby specialist or rehabilitation facility, it is often difficult for personnel at the new facility to access the patient’s electronic health records... Read more

Point of Care

view channel
Image: Steripath improves the diagnostic accuracy and timeliness of sepsis test results (Photo courtesy of Magnolia)

All-in-One Device Reduces False-Positive Diagnostic Test Results for Bloodstream Infections

Blood cultures are considered the gold standard diagnostic test for the detection of blood stream infections, such as sepsis. However, positive blood culture results can be frequently wrong, and about... Read more

Business

view channel
Image: The global patient positioning systems market is projected to reach USD 1.7 billion by 2027 (Photo courtesy of Pexels)

Global Patient Positioning Systems Market Driven by Increasing Chronic Diseases

The global patient positioning systems market is projected to grow at a CAGR of 4% from USD 1.4 billion in 2022 to USD 1.7 billion by 2027, driven by increasing technological advancements in medical devices,... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.